GPRC5D/CD3 BiTE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GPRC5D/CD3 BiTE, covering 2025-08-06 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma [Phase 2]